Being a proficient and comprehensive,  Lung Cancer Liquid Biopsy Market research report puts a light on primary and secondary drivers, market share, leading segments, possible sales volume, and geographical analysis. This market research report contains thorough analysis of the market structure along with forecast of the various segments and sub-segments of the market. A numerous markets, marketing strategies, trends, future products and rising opportunities are taken into consideration while studying market and preparing this report. The chief areas covered in the widespread Lung Cancer Liquid Biopsy Market report include market definition, market segmentation, competitive analysis and research methodology.

Entire Lung Cancer Liquid Biopsy Market report can be mainly categorised into four major areas which are market definition, market segmentation, competitive analysis and research methodology. This market research report comprises of key information about the industry, market segmentation, important facts and figures, expert opinions, and the latest developments across the globe. Market research studies conducted in this business report are very attentive for the businesses which help them with the better decision making and develop better strategies about production, marketing, sales and promotion. A team of innovative analysts, enthusiastic forecasters, knowledgeable researchers and experienced industry experts work harder and 24*7 to structure the most excellent Lung Cancer Liquid Biopsy Market report.

According to the National Cancer Institute, lung cancer is the leading cause of death in the United States. Lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer deaths worldwide, with an estimated 1.8 million new cases in 2012. Currently, the 5-year overall survival rate for lung cancer is 17%-22%, though survival varies depending on the stage of diagnosis. Liquid biopsy has enormous potential in lung cancer diagnosis.

Data Bridge Market Research analyses that the lung cancer liquid biopsy market which was USD 0.30 billion in 2022, is expected to reach USD 1.38 billion by 2030, at a CAGR of 21% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Explore Further Details about This Research Lung Cancer Liquid Biopsy Market Report https://www.databridgemarketresearch.com/reports/global-lung-cancer-liquid-biopsy-market 

REPORT METRIC

DETAILS

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Biomarker Type (CTC (Circulating Tumor Cells), ctDNA (Circulating tumor DNA), Exosomes and RNA), Application (Small Cell Lung Cancer and Non-Small Cell Lung Cancer), End-User (Diagnostic and Imaging Centres, Hospitals, Academic and Research Centers and Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Eurofins Scientific (Luxembourg), MDxHealth (Belgium), CareDx (U.S.), Immucor (U.S.), Thermo Fisher Scientific Inc. (U.S.), Menarini Silicon Biosystems (U.S.), QIAGEN (Germany), Guardant Health (U.S.), Exact Sciences Corporation (U.S.), Myriad Genetics, Inc. (U.S.), LungLife AI, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Natera, Inc. (U.S.), CARDIFF ONCOLOGY, INC. (U.S.), Exosome Diagnostics Inc. (U.S.), Illumina, Inc. (U.S.), Genomic Health Inc. (U.S.) and F. Hoffmann-La Roche Ltd (Switzerland)

Market Opportunities
  • Rising incidence of lung cancer
  • Rising use of personalized medicine

 

Market Definition

Liquid biopsy is a non-invasive alternative to surgical biopsies that aids in detecting molecular biomarkers. Liquid biopsy eliminates the need for costly invasive procedures by allowing doctors to detect diseases and make decisions using a blood sample from the patient. Liquid biopsy is a non-invasive alternative to surgical biopsies for detecting molecular biomarkers. Liquid biopsy is an essential component of precision medicine, with enormous diagnostic and treatment implications for oncology that can result in radical changes in clinical practice. It allows doctors to detect the onset of a disease or tumour by analyzing a simple blood sample. The presence of cancer cells or traces of RNA or DNA from cancer cells in the blood helps to determine the best course of treatment for a patient.

Global Lung Cancer Liquid Biopsy Market Dynamics

Drivers

  • Rising incidence of lung cancer

The rising incidence of lung cancer is one of the primary drivers of the lung cancer liquid biopsy market. Lung cancer is the leading cause of cancer death worldwide. The main causes of the rising prevalence of lung cancer are smoking, passive smoking, air pollution, and genetic abnormalities. These are the certain reasons which boost the growth of the market.

  • Rising use of personalized medicine

The liquid biopsy results can help physicians determine the treatment pattern for patients. These benefits are supplementing vendors' focus on providing a personalized treatment plan to lung cancer patients. Personalized medicine ensures that medications are targeted and effective. One of the key factors expected to positively impact the lung cancer liquid biopsy market during the forecast period.

 

Answers That the Report Acknowledges:

  • Lung Cancer Liquid Biopsy Market size and growth rate during forecast period
  • Key factors driving the Lung Cancer Liquid Biopsy Market
  • Key market trends cracking up the growth of the Lung Cancer Liquid Biopsy Market.
  • Challenges to Lung Cancer Liquid Biopsy Market growth
  • Key vendors of Lung Cancer Liquid Biopsy Market
  • Opportunities and threats faces by the existing vendors in Global Lung Cancer Liquid Biopsy Market
  • Trending factors influencing the market in the geographical regions
  • Strategic initiatives focusing the leading vendors
  • PEST analysis of the Lung Cancer Liquid Biopsy Market in the five major regions

Why choose Data Bridge Market Research?

  • Modern technologies, such as artificial intelligence, to provide updated industry growth.
  • DBMR team provides clients with the top notch Lung Cancer Liquid Biopsy Market research report.
  • Interaction with research scientists and development heads to understand the nature of the Lung Cancer Liquid Biopsy Market more precisely.
  • 24/7 availability of services.
  • Data collection from implementation vendors, service providers, and raw material suppliers to provide a clear perspective with Forecast period.

DBMR team uses very fair means to gather information that is scrutinized at every stage while structuring an influential Lung Cancer Liquid Biopsy Market size

Browse Related Reports: 

Livestock Analytics Market  Size And Share Analysis Report,

Light Duty Vehicle Market  by Size, Share, Forecast, & Trends

Driveline Market  Size Report- Industry Growth Analysis

Coastal Patrol Military Vessels Market  Size, Industry Share Forecast

Automotive Torque Sensor Market  Size, Share, Growth | Opportunities,

Deepwater Hydrocarbon Exploration Market  Size, Share Analysis Report

Phenolic Board Market  Size, Share, Growth Analysis

Mineral Spirits Market  Size, Share, Growth

Bioresorbable Polymers Market  Size, Share & Trends: Report

Military Aerospace Coatings Market  Size, Share, Industry, Forecast

About Data Bridge Market Research:

 US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com